Angelico M, Alvaro D, Cantafora A, Masella R, Gaudio E, Gandin C, Ginanni Corradini S, Ariosto F, Riggio O, Capocaccia L
II Division of Gastroenterology, University of Rome La Sapienza, Italy.
Gastroenterology. 1991 Jul;101(1):228-37. doi: 10.1016/0016-5085(91)90482-z.
Lysophosphatidylcholine is a major metabolic product in the plasma and cellular turnover of phospholipids, with well-known membrane-toxic and proinflammatory properties. Because the liver plays a key role in plasma lysophosphatidylcholine removal and biotransformation and because virtually nothing is known of these processes in a diseased organ, the hepatobiliary metabolism of lysophosphatidylcholine was investigated in rats with carbon tetrachloride-induced liver cirrhosis. Twelve adult male Wistar rats with histologically confirmed cirrhosis and 8 control animals were fitted with jugular and biliary catheters and allowed to recover. The animals were kept under constant IV infusion of taurocholate (1 mumol/min). Two microcuries of sn-1[14C]palmitoyl-lysophosphatidylcholine was administered as a single bolus. The fate of the injected radioactivity, including removal from plasma, uptake, and subcellular location in the liver and molecular and aggregative forms, was studied by combined chromatographic and radiochemical methods. Major findings were (a) that lysophosphatidylcholine has a prolonged permanence in plasma of cirrhotic rats, due both to decreased hepatic clearance and to depressed conversion into phosphatidylcholine; (b) that the rate of lysophosphatidylcholine acylation is much slower in the cirrhotic than in the normal liver, both at the microsomal and at the cytosolic level; (c) that cytosolic lysophosphatidylcholine in the cirrhotic liver, but not in the normal liver, is predominantly non-protein bound; (d) that the strict molecular selectivity of lysophosphatidylcholine acylation observed in controls is partially lost in cirrhosis; and (e) that a consistent fraction of lysophosphatidylcholine is converted into triacylglycerols in cirrhotics but not in controls. These findings show a profound derangment of lysophosphatidylcholine handling and processing in the cirrhotic liver, which is of potential pathogenetic significance.
溶血磷脂酰胆碱是磷脂在血浆和细胞周转过程中的主要代谢产物,具有众所周知的膜毒性和促炎特性。由于肝脏在血浆溶血磷脂酰胆碱的清除和生物转化中起关键作用,且在患病器官中对这些过程几乎一无所知,因此在四氯化碳诱导的肝硬化大鼠中研究了溶血磷脂酰胆碱的肝胆代谢。12只经组织学证实为肝硬化的成年雄性Wistar大鼠和8只对照动物植入颈静脉和胆管导管并使其恢复。动物持续静脉输注牛磺胆酸盐(1 μmol/分钟)。单次推注给予2微居里的sn-1[14C]棕榈酰溶血磷脂酰胆碱。通过色谱和放射化学方法相结合,研究了注入放射性物质的去向,包括从血浆中的清除、摄取、在肝脏中的亚细胞定位以及分子和聚集形式。主要发现如下:(a)溶血磷脂酰胆碱在肝硬化大鼠血浆中的滞留时间延长,这既是由于肝脏清除率降低,也是由于转化为磷脂酰胆碱的过程受到抑制;(b)在微粒体和胞质水平上,肝硬化肝脏中溶血磷脂酰胆碱的酰化速率比正常肝脏慢得多;(c)肝硬化肝脏中的胞质溶血磷脂酰胆碱主要是非蛋白结合型,而正常肝脏中并非如此;(d)在对照组中观察到的溶血磷脂酰胆碱酰化严格的分子选择性在肝硬化中部分丧失;(e)在肝硬化大鼠中,有相当一部分溶血磷脂酰胆碱转化为三酰甘油,而对照组中则没有。这些发现表明肝硬化肝脏中溶血磷脂酰胆碱的处理和加工存在严重紊乱,这具有潜在的致病意义。